Boothbay Fund Management, LLC Arbutus Biopharma Corp Transaction History

Boothbay Fund Management, LLC

$3.37 Billion
Q2 2024

A detailed history of Boothbay Fund Management, LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 612,277 shares of ABUS stock, worth $2.41 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

612,277

Previous 612,277 -0.0%

Holding current value

$2.41 Million

Previous $1.58 Million 19.76%

% of portfolio

0.06%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.26 - $2.92 $358,546 - $463,255	158,649 Added 34.97%	612,277 $1.58 Million
Q4 2023 Feb 14, 2024	SELL	$1.69 - $2.54 $64,377 - $96,756	-38,093 Reduced 7.75%	453,628 $1.13 Million
Q2 2023 Aug 14, 2023	SELL	$2.24 - $3.06 $296,275 - $404,733	-132,266 Reduced 21.2%	491,721 $1.13 Million
Q1 2023 May 15, 2023	SELL	$2.23 - $3.1 $197,756 - $274,908	-88,680 Reduced 12.44%	623,987 $1.89 Million
Q4 2022 Feb 14, 2023	SELL	$1.91 - $2.85 $104,540 - $155,989	-54,733 Reduced 7.13%	712,667 $1.66 Million
Q3 2022 Nov 14, 2022	BUY	$1.88 - $2.88 $404,448 - $619,580	215,132 Added 38.95%	767,400 $1.47 Million
Q2 2022 Aug 15, 2022	BUY	$1.98 - $3.17 $122,057 - $195,414	61,645 Added 12.56%	552,268 $1.5 Million
Q1 2022 May 16, 2022	BUY	$2.42 - $3.98 $77,394 - $127,284	31,981 Added 6.97%	490,623 $1.46 Million
Q4 2021 Feb 14, 2022	BUY	$3.11 - $4.61 $928,776 - $1.38 Million	298,642 Added 186.65%	458,642 $1.78 Million
Q3 2021 Nov 15, 2021	BUY	$2.65 - $4.62 $265,000 - $462,000	100,000 Added 166.67%	160,000 $686,000
Q2 2021 Aug 16, 2021	BUY	$2.5 - $3.51 $41,955 - $58,904	16,782 Added 38.83%	60,000 $182,000
Q1 2021 May 17, 2021	SELL	$3.14 - $4.84 $12,754 - $19,660	-4,062 Reduced 8.59%	43,218 $144,000
Q4 2020 Feb 12, 2021	BUY	$2.76 - $4.97 $94,011 - $169,288	34,062 Added 257.69%	47,280 $168,000
Q3 2020 Nov 16, 2020	BUY	$1.75 - $6.2 $23,131 - $81,951	13,218 New	13,218 $41,000
Q1 2020 May 15, 2020	SELL	$1.01 - $3.42 $21,473 - $72,712	-21,261 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.87 - $2.89 $18,497 - $61,444	21,261 New	21,261 $59,000
Q3 2018 Nov 14, 2018	SELL	$7.85 - $12.35 $376,800 - $592,800	-48,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$5.0 - $7.35 $240,000 - $352,800	48,000 New	48,000 $350,000

Others Institutions Holding ABUS

# of Institutions

138

Shares Held

95.4M

Call Options Held

3.44M

Put Options Held

377K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $591M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Account

Boothbay Fund Management, LLC Arbutus Biopharma Corp Transaction History